We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Bone effects of glitazones and other anti-diabetic drugs.
Current Drug Safety 2008 September
Several lines of evidence suggest that diabetes causes harmful effects on bone. This may be due to the diabetic disease per se i.e., high as well as low insulin and glucose levels may cause direct effects on bone metabolism. Moreover, diabetes associated co-morbidity, including impaired vision and neuropathy may affect physical activity and postural stability with effects on bone mineral density (BMD) and fracture risk. In type 1 diabetes, a 7-fold increase in risk of fracture has been reported but there is controversy about whether risk of fracture can be reduced by tight glycaemic control. However, the increased fracture risk seems at least in part to be associated with complications of diabetes, and therefore good metabolic control may reduce the risk of fracture in the long term. Risk of fracture is also increased in type 2 diabetes, but there are no good-quality studies comparing effects on bone of insulin with oral anti-diabetic agents. However, there are differences between bone effects of different oral anti-diabetic drugs. From a bone perspective, metformin and sulphonylureas should be chosen rather than glitazones, as randomised trials have shown that glitazones decrease BMD and increase fracture risk. The mechanism of action is probably through decreased bone formation. Conversely, metformin and sulphonylureas may counter the harmful bone effects of diabetes, as risk of fracture in patients treated with these drugs seems to be reduced compared with the general population. Studies are needed to elucidate mechanisms of action by which metformin and sulphonylureas may affect bone.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app